DISEASE INDICATIONS:
Alagille syndrome
MANUFACTURER:
Mirum Pharmaceuticals
USAGE:
Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Livmarli (maralixibat) is a prescription medication that belongs to the drug class of bile acid transporter inhibitors. It is used to treat cholestatic pruritus (itch) in patients with Alagille syndrome who are at least 1 year old.
